Drone Policy 2023 - Information Technology Development Agency 2026

This part of the Ayush drug quality scheme focuses on keeping a close watch on the safety Read More... of Ayurveda, Siddha, Unani, and Homoeopathy (ASU&H) medicines and cracking down on false ads. Read less

Details

The Indian government, through the Ministry of Ayush, is committed to ensuring the quality and safety of traditional medicines. A key component of this effort is the 'Pharmacovigilance of ASU&H Drugs Including Surveillance of Misleading Advertisements' under the Ayush Oushadhi Gunvatta evam Uttpadan Samvardhan Yojana (AOGUSY). This initiative acts as a watchdog, collecting vital data to confirm the clinical safety of ASU&H drugs and to keep a sharp eye on any deceptive advertisements related to these medicines or the systems they belong to.

What Is This Scheme About?

Essentially, this scheme aims to build a strong system that monitors if ASU&H drugs are safe for use. It also actively looks out for advertisements that might mislead people about the benefits or effectiveness of these medicines. The goal is to make sure that consumers get safe products and accurate information.

Who Can Benefit From This Scheme?

This scheme is primarily designed to benefit healthcare institutions, practitioners, and ultimately, the public. It provides a framework for reporting issues and ensures that regulatory bodies have the evidence needed to take action.

Why This Scheme Is Important

Ensuring the safety of medicines is paramount for public health. By actively monitoring for adverse reactions and tackling misleading claims, this scheme helps maintain trust in ASU&H systems, promotes responsible advertising, and supports informed healthcare choices for everyone.

Objective

This part of the Ayush drug quality scheme focuses on keeping a close watch on the safety of Ayurveda, Siddha, Unani, and Homoeopathy (ASU&H) medicines and cracking down on false ads.

Benefits

The following measures have been initiated under the Drone Policy 2023 to boost the drone sector:

Giving a major boost to service delivery and governance through the use of drones in the difficult terrains of the state.
Encouraging innovation and development in drone technology.
Strengthening the Drone System Design and Manufacturing (DSDM) and Drone-Based Services (DES) ecosystem.
Maximizing the benefits of drone technology for the state by promoting collaboration between industry, administration, and academia.
Providing benefits under the policy to drone service providers, drone manufacturers, drone investors, drone-related startups, the youth of Uttarakhand, universities, ITIs, and polytechnic colleges.
Developing a Public-Private Partnership (PPP) framework for the use of drones.
Rewarding startups, companies, and individuals excelling in drone manufacturing and drone-related services.
Establishing Drone Centers of Excellence.
Introducing various incentive schemes.

Sources and references

Guidelines (Page No. 241)

Who Can Apply?

The scheme is looking for specific types of organisations to help run its safety monitoring and surveillance efforts. These are divided into two main categories:

For Peripheral Pharmacovigilance Centres (PPvCs):

Ayush teaching hospitals that are officially recognised under the relevant Indian medical councils (NCISM/NCH Act, IMCC Act, HCC Act, etc.).
Healthcare facilities and research institutions offering ASU&H services that have NABH accreditation or are government-run.
Organisations that have the necessary technical skills and infrastructure to monitor and report drug safety information.
Institutions that have a good track record in similar projects will be given preference.
If an institution has previously received funding from the Central Government, it must have completed all previous project reports and have no adverse findings.

For Intermediary and National Centres:

Only those institutions that the Ministry of Ayush has specifically appointed as National or Intermediary Pharmacovigilance Centres are eligible.

How to Apply

Institutions looking to become Peripheral Pharmacovigilance Centres (PPvCs) need to follow these steps:

Prepare and submit an application form along with a concept note detailing your proposal for participating as a PPvC.
Provide an undertaking confirming your commitment to follow all pharmacovigilance rules and reporting requirements.
Submit detailed information about your current infrastructure, available staff, and equipment.
Include a project proposal outlining your objectives, a clear action plan, key milestones, and a breakdown of the budget.
Attach a recommendation letter from the head of your institution.
If you have received Government funding before, you'll need to submit utilization certificates for those projects.
Be ready to provide any other documents that might be asked for during the process.

The Ministry of Ayush, through the National Pharmacovigilance Co-ordination Centre (NPvCC), will review these proposals. For designated Intermediary and National Centres, the process will be as directed by the Ministry of Ayush.

Documents You'll Need

If your institution wants to be a Peripheral Pharmacovigilance Centre (PPvC), make sure you have these documents ready:

The official application form and a concept note for your participation.
A formal undertaking to follow pharmacovigilance rules and submit reports.
Information about your existing infrastructure, staff, and equipment.
A detailed project proposal with your goals, action plan, milestones, and budget.
A recommendation letter from your institution's head.
Utilization certificates for any previous Government funding you've received (if applicable).
Any other documents the authorities might request.

FAQ’s

What is the main goal of this Ayush drug safety and misleading ad surveillance initiative?

The primary aim is to create a national system to monitor the safety of Ayurveda, Siddha, Unani, and Homoeopathy (ASU&H) drugs and to keep an eye out for any advertisements that might trick people.

Can you explain what pharmacovigilance means for ASU&H medicines?

Pharmacovigilance means carefully watching for any unwanted side effects or other safety concerns that arise from using Ayurveda, Siddha, Unani, and Homoeopathy drugs.

Who is in charge of running this pharmacovigilance programme?

This programme is managed by the Ministry of Ayush, working through a central coordinating centre and other centres that support its efforts.

How is the pharmacovigilance system structured?

It's set up in three levels: a National Pharmacovigilance Co-ordination Centre at the top, supported by Intermediary Pharmacovigilance Centres, and finally, Peripheral Pharmacovigilance Centres at the ground level.

Which types of institutions are eligible to become Peripheral Pharmacovigilance Centres?

Eligible institutions include recognised Ayush teaching hospitals, government-run or NABH-accredited healthcare facilities, and research institutions that have the right setup and expertise.

What kind of activities does this scheme component support?

It supports activities like reporting adverse drug reactions, monitoring misleading ads, running awareness campaigns, conducting research, and analysing all the collected data.

How are misleading advertisements tracked and dealt with?

We collect reports about misleading ads from doctors, patients, industry folks, and healthcare centres. These reports are then checked to take appropriate action.

What kind of financial help is available under this initiative?

Financial support is given to cover costs for staff, public awareness campaigns, educational materials, unexpected expenses, and managing the overall programme at the different pharmacovigilance centres.

How are the applications for becoming a pharmacovigilance centre evaluated?

Applications are first reviewed by an Intermediary Centre, and then the National Pharmacovigilance Co-ordination Centre assesses them before they are sent for final approval by the Ministry of Ayush.

If a place previously received government funds, does that make it ineligible?

No, receiving government funds before is not a barrier. The institution just needs to have settled all utilisation certificates for past projects and have no adverse remarks on its performance.

What are the main duties of a Peripheral Pharmacovigilance Centre?

PPvCs are responsible for reporting any adverse drug reactions they encounter, watching out for misleading advertisements, and working closely with their Intermediary Centres.

How do selected centres receive their funding?

Funds are disbursed in stages, based on progress reports and audited financial statements that the centres submit to the NPvCC.

Why is this scheme crucial for public health in India?

This scheme is vital because it ensures that the ASU&H drugs available are safe and reliable, and it protects people from potentially harmful medicines and false advertising claims.